Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactase in IBS Patients With Lactose Intolerance (LION Trial)
NCT05100719Not yet recruiting
- Sponsor
- University of Pécs
- Start
- Sep 2022
- Primary completion
- Sep 2026
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of lactase in irritable bowel syndrome (IBS) and lactose intolerance, sponsored by University of Pécs. Primary endpoint: Total Symptom Score at 2 weeks. Planned start Sep 2022; status: not yet recruiting.
02
Drugs
lactase
03
Conditions
irritable bowel syndrome (IBS)lactose intolerance
Beyond the preview
Go deeper on NCT05100719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05100719.